Department of Urology, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Scand J Urol. 2021 Apr;55(2):135-141. doi: 10.1080/21681805.2021.1877344. Epub 2021 Jan 28.
The aim of this study was to give a collective overview on all available data sources on bladder cancer patients in the Nordic countries including the amount of detail and coverage.
National representatives from five Nordic countries were asked to fill out a questionnaire on available information regarding bladder cancer patients from databases in their respective countries. Additional information was retrieved from descriptions of the relevant registries.
: from all countries, information on stage and grade at transurethral resection of the bladder (TURB) could be retrieved. Details on procedures (TURB, instillation therapy, photodynamic diagnosis, and perioperative instillation) were varying within different databases. : in all Nordic countries, detailed information on cystectomy patients could be retrieved but with variable registration of complications. Completeness of available information on oncological treatment (radiation, chemotherapy, and immunotherapy) were varying. : Information on overall survival was available in all countries whereas recurrence-free survival and cancer-specific survival were available for some but not all patients depending on treatment modality.
Despite limitations, we found that it was possible to retrieve detailed information on diagnostics, treatment, and outcome for most aspects of bladder cancer in the Nordic countries on a population based, non-selected patient cohort.
本研究旨在对北欧国家所有膀胱癌患者的可用数据源进行综合概述,包括详细程度和覆盖范围。
要求来自五个北欧国家的国家代表填写一份关于其各自国家数据库中膀胱癌患者相关信息的问卷。还从相关登记处的描述中检索了其他信息。
从所有国家/地区都可以检索到经尿道膀胱肿瘤切除术(TURB)时的分期和分级信息。不同数据库中手术程序(TURB、灌洗治疗、光动力诊断和围手术期灌洗)的详细信息有所不同。在所有北欧国家,都可以检索到膀胱癌根治术患者的详细信息,但并发症的登记情况各不相同。关于肿瘤治疗(放疗、化疗和免疫治疗)的可用信息的完整性各不相同。所有国家都有总体生存率的信息,而部分而非所有患者的无复发生存率和癌症特异性生存率取决于治疗方式。
尽管存在局限性,但我们发现,在基于人群、非选择性患者队列的基础上,对于大多数膀胱癌方面,都可以检索到关于诊断、治疗和结局的详细信息。